Pfizer, BioNTech Ask FDA for Full Approval of Covid-19 Vaccine

Companies seek new standing for vaccine that would ease restrictions on distribution and advertising and give it the imprimatur of one of the world's most influential regulatory bodies.

 
U.S. Support for Patent Waiver Unlikely to Cost Covid-19 Vaccine Makers in Short Term

The Biden administration's move doesn't affect vaccine makers' deals to supply billions of dollars in doses, but could have longer-term consequences.

 
Carlyle Turns to SPX Capital in New Approach to Brazil

SPX Capital is absorbing members of Carlyle's team in Brazil and becoming a subadviser to the Washington, D.C., firm's $776 million South America buyout fund.

 
Hedge-Fund Founder Gets Prison Sentence for Fraud Tied to Neiman Bankruptcy

Dan Kamensky was sentenced to six months in prison for bankruptcy fraud over his attempt to quash a rival bid for shares of a Neiman Marcus Group business that he wanted to buy himself.

 
DraftKings Reports Higher Revenue, Costs as It Bets on Growth

The sports-betting platform benefited from a rollout in more states, but the gains came with significantly higher marketing expenses.

 
Cinemark, Studios Reach Deals on How Movies Are Shown

The agreements are aimed at establishing a model for how long movies would play in theaters before moving to home video.

 
NYSE to Delist Chinese Telecom Carriers After Rejecting Appeals

China's big three telecom carriers lost their appeals against being kicked off the New York Stock Exchange and will be delisted to comply with an investment ban introduced by former President Donald Trump.

 
Square's Edge Still Comes from Sellers

The financial-technology company's Cash App might be getting a lot of the attention right now, but linking up the app with a growing seller business is a big opportunity.

 
Grocers, Restaurants to Suppliers: Hurry Up, Make More

Retailers are implementing penalties for late or incomplete orders, adding pressure to food makers dealing with labor and ingredient shortages.

 
Barclays Activist Investor Sells Entire Stake

Edward Bramson's Sherborne Investors said it sold its entire stake in Barclays, giving up on a yearslong activist campaign to restructure the British bank with a major Wall Street presence.

(END) Dow Jones Newswires

May 07, 2021 17:15 ET (21:15 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.